Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
EP Technologies subsidiary will incorporate Super Dimension's localization sensors and navigational technology into its diagnostic mapping, intracardiac ultrasound, and therapeutic electrophysiology catheters following an equity investment in the Israeli firm announced Jan. 31. Separately, Boston Scientific acquires Canadian firm Cath Data's QMS 2 advanced mapping technology for the heart, regulatory approvals and related assets